Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Collaborating on registries, studies and surveys

As COVID-19 continues to spread, ESMO encourages the oncology community to run collaborative initiatives to answer important questions: How to manage cancer care in patients with suspected or confirmed COVID-19? How to identify risk factors and outcomes associated to the infection? How is COVID-19 impacting on oncology professionals? And others which become relevant as the situation evolves.

Impact of COVID-19 on Cancer Service Delivery

Peter Mac logo

A survey launched by the University of Melbourne and Peter MacCallum Cancer Centre to understand the global impact of COVID-19 on cancer services. The survey is open to medical oncologists, radiation oncologists, surgical oncologists and trainees in these fields, and aims to explore how the clinical management of cancer patients has changed during the COVID-19 pandemic.

Download invitation letter Take the survey

ESMO COVID-19 and CAncer REgistry Protocol


By pooling real-world data, the ESMOCoCARE Registry aims to quickly gather data and information about treatment approaches specifically focusing on the impact of SARS-CoV-2 on cancer patients who are suspected or confirmed to have the novel coronavirus disease (COVID19).
A better understanding of the unique effects of COVID-19 on patients with cancer and cancer survivors will allow to disseminate information and guidance for this particularly vulnerable group of patients and, ultimately, to propose approaches to mitigate the risks related to COVID-19 in cancer patients.

Read more

EHA initiative in collaboration with ESMO


The most urgent question and almost impossible to answer: which therapies should be administered/continued and which should be deferred/stopped? A survey amongst experts in their respective fields to get a better understanding of the risks. The survey will close on 27 April 2020.

Download invitation letter Take the survey

How are you reacting to the COVID-19 outbreak? An ESMO Resilience Task Force survey

ESMO Prisms Square

The ESMO Resilience Task Force, in collaboration with the ESMO Young Oncologists Committee, the ESMO Women for Oncology Committee, the ESMO Leaders Generation Programme Alumni Members and the OncoAlert Network, will carry out a series of global surveys to evaluate how oncologists and other oncology professionals across the world are affected by the challenges posed by the COVID-19 pandemic, assessing changes to routine practices, well-being and current levels of support.

Take the survey

TERAVOLT (Thoracic cancERs international coVid 19 cOLlaboraTion) registry for thoracic cancers

Teravolt logo

A global consortium designed to gather information on patients with thoracic cancer infected with COVID-19 regardless of therapies administered. The initiative currently involves more than 100 investigators worldwide.

Main contact: Jennifer Whisenant, Vanderbilt-Ingram Cancer Center, Nashville, US. - E-Mail

Download invitation letter

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings